Neue Suche | Kongressdetail
Druckansicht
 
 

2nd Gene Therapy Immunogenicity

Evvnt Promotion / evvnt
-
03.08.2021 - 05.08.2021  Online
Time: 08:00 - 17:30
 
Kongressthemen
The 2nd Gene Therapy Immunogenicity Summit is the industry's definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate.

In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you're up to speed on the latest approaches to predict, measure
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Andrew Byrnes, Head Gene Transfer and Immunogenicity Branch, FDA, Klaudia Kuranda, Immunology Lead, Spark Therapeutics, David Markusic, Research Professor, IUPUI, Cathryn Clary, Acting Chief Medical Officer, Bridge Bio and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/754695-1?pid=4832
Frau Ellie Saunders
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Conference Only Ticket (First Release): $1599.0, Conference Only Ticket (Second Release): $1699.0, Conference Only Ticket (Third Release): $1899.0, Conference Only Ticket (Fourth Release): $1999.0, Conference Only Ticket (Final Price): $2099.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Helix - Forschung & Beratung WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der ÄrzteÄrzte der WeltSwiss Tropical and Public Health InstituteÖsterreichische Gesellschaft für Public HealthnewTree